Alcobra Ltd.
Tel Aviv, IL· latest recorded location
Alcobra Ltd. is named on 8 US grants and 10 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 8
- Published applications
- 10
- Inventors
- 11
- Granted in 2026 so far
- 0
- Most recent grant
- 3 Apr 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 2 |
| 2014 | 2 | 0 |
| 2015 | 0 | 2 |
| 2016 | 1 | 3 |
| 2017 | 3 | 0 |
| 2018 | 1 | 0 |
By publication year.
Technology areas
Share of 18 documents
Recent patents
- Abuse deterrent formulations of amphetamine3 Apr 2018US 9,931,303 B1
- Methods of treating fragile X syndrome and related disorders26 Dec 2017US 9,851,354 B2
- Methods of determining response to therapy26 Dec 2017US 9,851,355 B2
- Method for decreasing symptoms of alcohol consumption7 Nov 2017US 9,808,446 B2
- Substituted pyridoxine-lactam carboxylate-salts30 Aug 2016US 9,428,458 B2
- Methods of determining response to therapy28 Jul 2016US 2016/0216265 A1
- Method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition14 Jul 2016US 2016/0199362 A1
- Methods of treating fragile x syndrome and related disorders7 Jul 2016US 2016/0193199 A1
- Method for decreasing symptoms of alcohol consumption30 Jul 2015US 2015/0209338 A1
- Substituted pyridoxine-lactam carboxylate-salts22 Jan 2015US 2015/0025111 A1
Most cited
By later US patents